NIH halts study of plasma in COVID-19 treatment citing lack of benefit
By (0)
The NIH halted a study using blood plasma from recovered COVID-19 patients to prevent severe disease in other patients because it was ineffective. File photo by Bill Greenblatt/UPI | License Photo
March 2 (UPI) Officials at the National Institutes of Health on Tuesday stopped an ongoing clinical trial evaluating the use convalescent plasma for treatment of severe COVID-19, due to lack of clear clinical benefit.
The trial, which focused on emergency-room patients with mild to moderate symptoms of infection, found the approach to be safe, the agency said.
Fauci says he would have no hesitancy whatsoever taking the newly authorized Johnson & Johnson vaccine businessinsider.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.co.za Daily Mail and Mail on Sunday newspapers.
Fauci urges Americans to get vaccinated, not to cherry-pick the brand they receive businessinsider.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.co.za Daily Mail and Mail on Sunday newspapers.